Evidence map›Paper›PMID 26728714›Full record

ArticleBMC musculoskeletal disorders2016

Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment.

Rhys D R Evans, Christopher M Laing, Coziana Ciurtin, Stephen B Walsh

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC musculoskeletal disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Urinary CD4Scientific reports · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Rhys D R EvansUCL Centre for Nephrology, UCL Medical School, Rowland Hill Street, London, NW3 2PF, UK. rhydrevans@gmail.com.
Christopher M LaingUCL Centre for Nephrology, UCL Medical School, Rowland Hill Street, London, NW3 2PF, UK. chris.laing@nhs.net.
Coziana CiurtinDepartment of Rheumatology, University College London Hospital, NHS Trust, 3rd Floor Central, 250 Euston Road, London, NW1 2PG, UK. c.ciurtin@ucl.ac.uk.
Stephen B WalshUCL Centre for Nephrology, UCL Medical School, Rowland Hill Street, London, NW3 2PF, UK. stephen.walsh@ucl.ac.uk.
Roland Hill (United Kingdom) · GBUniversity College Hospital · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary Sjögren syndrome (pSS) is a common autoimmune condition which primarily affects epithelial tissue, often including the kidney causing either tubulointerstitial nephritis (TIN) or more rarely, an immune complex related glomerulonephritis.

methodsWe describe the clinical, biochemical and histological characteristics of 12 patients with pSS related TIN and their response to treatment with antiproliferative agents. All 12 patients were investigated and treated at the UCL Centre for Nephrology in London.

resultsAll patients had TIN demonstrated via needle biopsy; immunophenotyping showed that the interstitial infiltrate was predominantly a CD4+ T-cell infiltrate. Urinary acidification testing demonstrated distal renal tubular acidosis in 8 patients. Proximal tubular dysfunction was present in 5 patients. All but 1 patient were treated with antiproliferative agents and most also with a reducing course of steroids. In the treated patients, there was a significant improvement in the serum creatinine and measured GFR.

conclusionPatients with pSS TIN have significant renal impairment and other functional tubular defects. There is a mononuclear lymphocytic infiltrate on renal biopsy and this appears to be mainly a CD4+ T-cell infiltrate. Treatment with mycophenolate (and corticosteroids) improves the renal function in patients with pSS TIN.

Indexed as

Adrenal Cortex HormonesAdultAgedFemaleHumansImmunosuppressive AgentsMaleMiddle AgedMycophenolic AcidNephritis, InterstitialSjogren's SyndromeTreatment OutcomeAdrenal Cortex HormonesImmunosuppressive AgentsMycophenolic Acid

Identifiers

PMID26728714
PMCPMC4700638
OpenAlexW2229335880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.